Skip to main content
ADMA
NASDAQ Life Sciences

ADMA Biologics Posts 22-Cent Q3 EPS

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$11.14
Mkt Cap
$2.347B
52W Low
$7.21
52W High
$20.458
52W Position info
55% above low
Off High info
46% below high
Rel. Volume info
4.2× avg
Market data snapshot near publication time

ADMA sits 55% above its 52-week low of $7.21 on elevated volume (4.2× avg).

Summary

ADMA reported third-quarter earnings per share of 22 cents, per Dow Jones Newswires, with Q3 net income of USD 49.884 million and revenue up 5% to $141.1 million. That follows Q2 2026 net income of $37.8 million on $124.4 million of revenue, when ASCENIV growth offset BIVIGAM weakness. The company also increased its adjusted earnings outlook. The company has been returning capital aggressively, including a $125M accelerated share repurchase launched in March as part of a $200M 2026 plan, and buybacks lower the share count, which lifts EPS independent of operating results.

At the time of this announcement, ADMA was trading at $11.14 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $7.21 to $20.46. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ADMA - Latest Insights

ADMA
Nov 04, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $14.00
Real-time Price: $13.53 info
Change: -$0.470 (-3%) info
Market Cap: $3.008B info
ADMA
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $9.98
Real-time Price: $13.53 info
Change: +$3.55 (+36%) info
Market Cap: $3.008B info
ADMA
Aug 05, 2026, 5:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.11
Real-time Price: $13.53 info
Change: +$4.42 (+49%) info
Market Cap: $3.008B info
ADMA
Jul 16, 2026, 10:09 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $8.88
Real-time Price: $13.53 info
Change: +$4.65 (+52%) info
Market Cap: $3.008B info
ADMA
Jul 07, 2026, 6:33 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $9.16
Real-time Price: $13.53 info
Change: +$4.37 (+48%) info
Market Cap: $3.008B info